(Q37570220)

21 August 2017

1 reference

title

Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin (English)

1 reference

21 August 2017

1 reference

1

Christos D Katsetos

1 reference

21 August 2017

3

Agustin Legido

1 reference

21 August 2017

5

Pavel Dráber

1 reference

21 August 2017

2

Eduarda Dráberová

1 reference

21 August 2017

Charles Dumontet

4

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Journal of Cellular Physiology

21 August 2017

published in

1 reference

21 August 2017

volume

221

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

505-513

1 reference

Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells

21 August 2017

cites work

1 reference

Characterization of posttranslational modifications in neuron-specific class III beta-tubulin by mass spectrometry

21 January 2018

1 reference

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

21 January 2018

1 reference

Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity

21 January 2018

1 reference

Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study

21 January 2018

1 reference

Do beta-tubulin mutations have a role in resistance to chemotherapy?

21 January 2018

1 reference

Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin

21 January 2018

1 reference

Cancer stem cells and glioma

21 January 2018

1 reference

Tubulin and microtubule structure

21 January 2018

1 reference

Re-evaluating centrosome function

21 January 2018

1 reference

Expression of class III beta-tubulin in normal and neoplastic human tissues

21 January 2018

1 reference

Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity

21 January 2018

1 reference

Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies

21 January 2018

1 reference

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.

21 January 2018

1 reference

Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?

21 January 2018

1 reference

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

21 January 2018

1 reference

Tubulin nitration in human gliomas

21 January 2018

1 reference

Angiogenesis in gliomas: biology and molecular pathophysiology

21 January 2018

1 reference

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.

21 January 2018

1 reference

Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.

21 January 2018

1 reference

Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel

21 January 2018

1 reference

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

21 January 2018

1 reference

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

Taxol: mechanisms of action and resistance

21 January 2018

1 reference

Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.

21 January 2018

1 reference

Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins

21 January 2018

1 reference

Requirement for the betaI and betaIV tubulin isotypes in mammalian cilia

21 January 2018

1 reference

The roles of cys124 and ser239 in the functional properties of human betaIII tubulin

21 January 2018

1 reference

Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo

21 January 2018

1 reference

DNA repair and cancer stem-like cells--potential partners in glioma drug resistance?

21 January 2018

1 reference

How do microtubule-targeted drugs work? An overview

21 January 2018

1 reference

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

21 January 2018

1 reference

BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability

21 January 2018

1 reference

Class III beta-tubulin isotype (beta III) in the adrenal medulla: I. Localization in the developing human adrenal medulla.

21 January 2018

1 reference

Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status

21 January 2018

1 reference

Class III β‐tubulin in human development and cancer

21 January 2018

1 reference

Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology

21 January 2018

1 reference

Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines

21 January 2018

1 reference

Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells

21 January 2018

1 reference

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

21 January 2018

1 reference

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

21 January 2018

1 reference

Phosphorylation of beta III-tubulin.

21 January 2018

1 reference

Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker

21 January 2018

1 reference

Malignant glioma progression and nitric oxide

21 January 2018

1 reference

Posttranslational modification of class III beta-tubulin

21 January 2018

1 reference

The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis

21 January 2018

1 reference

TuJ1 (class III beta-tubulin) expression suggests dynamic redistribution of follicular dendritic cells in lymphoid tissue.

21 January 2018

1 reference

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

21 January 2018

1 reference

Immunological discrimination of beta-tubulin isoforms in developing mouse brain. Post-translational modification of non-class-III beta-tubulins

21 January 2018

1 reference

The presence of neuron-associated microtubule proteins in the human U-251 MG cell line. A comparative immunoblot and immunohistochemical study

21 January 2018

1 reference

Molecular pathology of malignant gliomas

21 January 2018

1 reference

The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies

21 January 2018

1 reference

Proliferative status of tumor stem cells may be correlated with malignancy grade of human astrocytomas

21 January 2018

1 reference

Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells

21 January 2018

1 reference

Dynamic instability of microtubule growth

21 January 2018

1 reference

Molecular mechanisms of patupilone resistance

21 January 2018

1 reference

Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.

21 January 2018

1 reference

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo

21 January 2018

1 reference

Mechanisms of Taxol resistance related to microtubules.

21 January 2018

1 reference

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

21 January 2018

1 reference

Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region

21 January 2018

1 reference

A population of human brain parenchymal cells express markers of glial, neuronal and early neural cells and differentiate into cells of neuronal and glial lineages.

21 January 2018

1 reference

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

21 January 2018

1 reference

The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms

21 January 2018

1 reference

'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis

21 January 2018

1 reference

Glioblastoma cells release factors that disrupt blood-brain barrier features

21 January 2018

1 reference

Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

21 January 2018

1 reference

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

21 January 2018

1 reference

Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

21 January 2018

1 reference

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins

21 January 2018

1 reference

Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics

21 January 2018

1 reference

Mechanisms of tumor cell invasion and angiogenesis in the central nervous system

21 January 2018

1 reference

Subsets of glioblastoma multiforme defined by molecular genetic analysis

21 January 2018

1 reference

Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation.

21 January 2018

1 reference

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.21870

1 reference

21 August 2017

1 reference